Can a protein infusion cut dangerous fluid buildup in liver disease?
NCT ID NCT05867602
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study tests whether giving a higher dose of albumin (a protein) to people with advanced liver cirrhosis and fluid buildup (ascites) can reduce the need for fluid drainage procedures and prevent complications. About 100 adults with hard-to-treat ascites will receive either high-dose or standard-dose albumin infusions. The goal is to see if the higher dose improves outcomes like survival and reduces infections or kidney problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASCITES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor St' Lukes Medical center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- A new procedure may offer relief for Cirrhosis-Related fluid buildup
- Bringing the hospital home: a new model for End-Stage liver care
- Could a poop pill protect the liver? trial tests fecal transplants against cirrhosis complications
- Can smarter antibiotic choices curb superbugs in liver disease?
- Early liver shunt may reduce need for repeated fluid drains in ascites patients